Our research projects

Having diabetes can lead to damaged blood vessels in the retina at the back of the eye, caused by high blood sugar levels. This can lead to vision problems and sight loss. Dr Judith Lechner wants to find out if a protective protein can be used to repair and reduce this damage, and potentially be used as a new treatment option in the future.

Some people develop type 1 diabetes very quickly, but in others, the immune attack that causes type 1 diabetes progresses slowly. Professor Kathleen Gillespie and her PhD student will look for genetic differences between these groups of people to find out why this is. In the future, this could lead to life-changing treatments to delay or prevent type 1 diabetes.

We know that a person’s genetic makeup is important in type 2 diabetes but we don’t know exactly how they’re linked. Dr Jennings is going to study genes related to beta cell and pancreas development and the 3D switches that control them. This will give us a better understanding of why type 2 diabetes develops, which could lead to new therapies to prevent and treat it. 

Insulin-making beta cells have recycling centres, called lysosomes, which help to break down waste inside our cells. When someone has type 2 diabetes, this process stops working properly. Dr Aida Martinez-Sanchez wants to investigate why this happens by studying the role a protein called M6PR, plays in controlling how lysosomes in beta cells behave. Understanding this could help researchers to develop better treatments for type 2 diabetes and improve those already available. 

Proteins are key to keeping insulin-making beta cells healthy. But in type 2 diabetes, something goes wrong with the process where beta cells make new proteins. Dr Daniela Nasteska will study this in detail to understand what goes wrong and how this leads to type 2 diabetes. This could pave the way to new treatments for type 2 diabetes and unlock better ways to grow beta cells in the lab, ready for transplant. 

Type 1 diabetes develops when the immune system attacks and destroys insulin-making beta cells. Dr Matthew Johnson and his team will study a rare type of diabetes that could help us better understand why the immune system turns on beta cells, and how this process may differ between people. This could pave the way towards new treatments that protect the pancreas from harm in people with or at risk of type 1 diabetes.

Using steroids can increase the risk of developing a specific type of diabetes called steroid diabetes. It can also lead to higher blood sugar levels in people with other types of diabetes. Dr Katharine Lazarus will explore if a type 2 diabetes medication, called semaglutide, could help to lower this risk and lower blood sugar levels. This study could pave the way for a safer steroid use for people with or at risk of diabetes.

High blood sugar levels can damage blood vessels, and over time this can lead to diabetes complications. Professor David Long will enhance a pioneering new way of growing blood vessels in the lab to study how they behave in diabetes. Understanding what happens to blood vessels in high sugar levels could help researchers to develop new treatments that prevent or slow all sorts of complications. 

Women who’ve had gestational diabetes have a 10-fold higher risk of later developing type 2 diabetes. Dr Nerys Astbury and her PhD student will develop a ‘calculator’ to predict which women have the highest risk. They’ll then create a new, tailored treatment that aims to help women reduce their risk. This research could help to prevent more cases of type 2 in women who’ve had gestational diabetes, giving women healthier futures.